GlassScriptPhysician profile
Matthew R Wainwright
NPI 1578032355
$3,371.51
in general payments reported to CMS, 2019-2025
31 companies · $521 in 2025
The $521 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $418 · 2022: $623 · 2023: $1,123 · 2024: $686 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,331.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $461.01 | 2023-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| E.R. Squibb & Sons, L.L.C. | $348.30 | 2021-2025 | Camzyos, Eliquis |
| Abiomed | $336.07 | 2024-2025 | Impella |
| Atricure, INC. | $321.65 | 2021-2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $284.79 | 2022-2025 | Lifevest |
| Baxter Healthcare | $242.57 | 2021-2025 | Preveleak, Floseal |
| Amgen INC. | $164.31 | 2022 | |
| Smith+Nephew, INC. | $142.09 | 2021 | |
| Ethicon US, LLC | $113.86 | 2021-2025 | Echelon; Endopath, Stratafix, Enseal |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $104.06 | 2021 | |
| Medtronic, INC. | $103.67 | 2024-2025 | Penditure, Avalus, Corevalve Evolut R |
| Edwards Lifesciences Corporation | $76.59 | 2022-2023 | Mitris Resilia Mitral Valve |
| Chiesi USA, INC. | $70.34 | 2022 | |
| Novartis Pharmaceuticals Corporation | $59.93 | 2021-2024 | |
| Davol INC. | $50.51 | 2022-2024 | Progel Applicator Spray Tips |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $48.94 | 2022-2023 | Angiovac |
| Corcym INC | $44.37 | 2022-2024 | Memo 4d |
| Potrero Medical, INC. | $43.80 | 2021 | |
| Kestra Medical Technology Services, INC. | $43.78 | 2024-2025 | Assure Wcd |
| Lantheus Medical Imaging, INC. | $38.42 | 2022 | |
| Merck Sharp & Dohme LLC | $36.06 | 2022-2024 | Verquvo |
| Becton, Dickinson and Company | $35.25 | 2022 | |
| Haemonetics Corporation | $31.83 | 2023 | |
| Impulse Dynamics (USA) INC. | $27.59 | 2023 | Optimizer |
| Teleflex LLC | $27.16 | 2022 | |
| Solventum Corporation | $22.50 | 2024 | Prevena |
| Pfizer INC. | $22.25 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $20.65 | 2024 | Farxiga |
| Glaxosmithkline, LLC. | $20.33 | 2025 | Arexvy |
| Mimedx Group, INC. | $15.77 | 2024 | |
| Molnlycke Health Care US, LLC | $13.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Wainwright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.